sofosbuvir has been researched along with Sensitivity and Specificity in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asghar, S; Hussain, T; Irfan, M; Khalid, I; Khalid, SH; Khan, IU; Mehmood, Y; Shahzad, Y; Yousaf, AM | 1 |
| Babaei, A; Bahrami, G; Keshavarz, S; Miraghaei, S; Mohammadi, B | 1 |
| Abo-Zeid, MN; Atia, NN; El-Gizawy, SM; El-Shaboury, SR | 1 |
| Badr, KA; Basalious, EB; Rezk, MR | 1 |
| Baker, MM; Belal, TS; Hammad, SF | 1 |
| Andersson, K; Avorn, J; Brennan, T; Choudhry, NK; Krumme, AA; Matlin, OS; Najafzadeh, M; Shrank, WH | 1 |
| Guerra, I; Krauth, C; Liersch, S; Rossol, S; Stahmeyer, JT | 1 |
7 other study(ies) available for sofosbuvir and Sensitivity and Specificity
| Article | Year |
|---|---|
Development and validation of a stability-Indicating RP-HPLC method for simultaneous estimation of sofosbuvir and velpatasvir in fixed dose combination tablets and plasma.
Topics: Animals; Carbamates; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Stability; Heterocyclic Compounds, 4 or More Rings; Limit of Detection; Plasma; Rats; Reproducibility of Results; Sensitivity and Specificity; Sofosbuvir; Tablets; Tandem Mass Spectrometry | 2019 |
Development and validation of a new HPLC-DAD method for quantification of sofosbuvir in human serum and its comparison with LC-MS/MS technique: Application to a bioequivalence study.
Topics: Chromatography, High Pressure Liquid; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Sofosbuvir; Tandem Mass Spectrometry; Therapeutic Equivalency | 2017 |
Simultaneous quantitation of two direct acting hepatitis C antivirals (sofosbuvir and daclatasvir) by an HPLC-UV method designated for their pharmacokinetic study in rabbits.
Topics: Animals; Antiviral Agents; Biological Availability; Carbamates; Chromatography, High Pressure Liquid; Drug Combinations; Hepacivirus; Hepatitis C; Imidazoles; Lactones; Limit of Detection; Liquid-Liquid Extraction; Male; Models, Animal; Pyrrolidines; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Sofosbuvir; Spectrophotometry, Ultraviolet; Sulfones; Ultrasonic Waves; Valine | 2018 |
Novel determination of sofosbuvir and velpatasvir in human plasma by UPLC-MS/MS method: Application to a bioequivalence study.
Topics: Adult; Carbamates; Chromatography, High Pressure Liquid; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Linear Models; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Sofosbuvir; Tandem Mass Spectrometry; Therapeutic Equivalency; Young Adult | 2018 |
Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissoluti
Topics: Antiviral Agents; Benzimidazoles; Carbamates; Chromatography, High Pressure Liquid; Fluorenes; Imidazoles; Limit of Detection; Pyrrolidines; Reproducibility of Results; Ribavirin; Sensitivity and Specificity; Sofosbuvir; Solubility; Valine | 2019 |
Cost-effectiveness of novel regimens for the treatment of hepatitis C virus.
Topics: Antiviral Agents; Benzimidazoles; Carbamates; Cost-Benefit Analysis; Disease Progression; Drug Costs; Drug Therapy, Combination; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Interferon-alpha; Patient-Specific Modeling; Pyrrolidines; Ribavirin; Sensitivity and Specificity; Simeprevir; Sofosbuvir; Sulfonamides; Uridine Monophosphate; Valine | 2015 |
Cost-Effectiveness of Treating Hepatitis C with Sofosbuvir/Ledipasvir in Germany.
Topics: Adult; Antiviral Agents; Benzimidazoles; Cost-Benefit Analysis; Fluorenes; Genotype; Germany; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Transplantation; Markov Chains; Middle Aged; Models, Theoretical; Public Health; Quality of Life; Quality-Adjusted Life Years; Sensitivity and Specificity; Sofosbuvir | 2017 |